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Abstract
Necroptosis, a recently discovered form of non-apoptotic programmed cell death, can be implicated in many pathological condi-
tions including neuronal cell death. Moreover, an inhibition of this process by necrostatin-1 (Nec-1) has been shown to be
neuroprotective in in vitro and in vivo models of cerebral ischemia. However, the involvement of this type of cell death in oxidative
stress–induced neuronal cell damage is less recognized. Therefore, we tested the effects of Nec-1, an inhibitor of necroptosis, in the
model of hydrogen peroxide (H2O2)-induced cell damage in human neuroblastoma SH-SY5Yand murine hippocampal HT-22 cell
lines. The data showed that Nec-1 (10–40 μM) attenuated the cell death induced by H2O2 in undifferentiated (UN-) and neuronal
differentiated (RA-) SH-SY5Y cells with a higher efficacy in the former cell type. Moreover, Nec-1 partially reduced cell damage
induced by 6-hydroxydopamine in UN- and RA-SH-SY5Y cells. The protective effect of Nec-1 was of similar magnitude as the
effect of a caspase-3 inhibitor in both cell phenotypes and this effect were not potentiated after combined treatment. Furthermore,
the non-specific apoptosis and necroptosis inhibitor curcumin augmented the beneficial effect of Nec-1 against H2O2-evoked cell
damage albeit only in RA-SH-SY5Y cells. Next, it was found that themechanisms of neuroprotective effect of Nec-1 against H2O2-
induced cell damage in SH-SY5Y cells involved the inhibition of lysosomal protease, cathepsin D, but not caspase-3 or calpain
activities. In HT-22 cells, Nec-1 was protective in two models of oxidative stress (H2O2 and glutamate) and that effect was blocked
by a caspase inhibitor. Our data showed neuroprotective effects of the necroptosis inhibitor, Nec-1, against oxidative stress–induced
cell damage and pointed to involvement of cathepsin D inhibition in the mechanism of its action. Moreover, a cell type–specific
interplay between necroptosis and apoptosis has been demonstrated.
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Introduction
Necroptosis, a form of non-apoptotic programmed cell death,
was shown to be activated in various models of acute (stroke,
traumatic brain, or spinal cord injuries) and chronic
(Alzheimer’s disease (AD), Parkinson’s disease (PD), and
amyotrophic lateral sclerosis (ALS)) neurodegenerative con-
ditions (Caccamo et al. 2017; Re et al. 2014; Vieira et al. 2014;
Yin et al. 2015). This cell death pathway can be distinguished
from apoptosis based on morphological and biochemical
criteria. The cell dying by necroptosis is characterized by the
loss of plasma membrane integrity, swelling of cellular organ-
elles, and lack of typical nuclear fragmentation. Moreover, it
can be activated by members of the tumor necrosis factor
(TNF) family (TNFR1, TNFR2, TRAILR1, TRAILR2), Fas
ligand, toll-like receptors (TLRs), lipopolysaccharides (LPS),
pathogens (bacteria and viruses), genotoxic stress, glutamate
(Glu), or calcium overload, and is thought to be a caspase-
independent process. A crucial step in initiation and execution
of necroptosis involves the activation of receptor-interacting
serine/threonine-protein (RIP) kinases (RIP1 and RIP3) and
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formation of the necrosome complex (Degterev et al. 2014;
Zhao et al. 2015).
In recent years, various inhibitors of necroptosis have been
experimentally tested in relation to various human pathologies
and used for mechanistic investigation of this process
(Degterev et al. 2005, 2008, 2013; Delehouzé et al. 2017;
Do et al. 2017; Li et al., 2018; Xie et al. 2013). Among them,
necrostatin-1 (Nec-1; methyl-thiohydantoin-tryptophan) was
the first to be identified and since then used the most frequent-
ly (Degterev et al. 2005, 2008). The neuroprotective potential
of Nec-1 and its analogs in cellular and animal models of
ischemia is rather well supported (Chavez-Valdez et al.
2012, 2016; Degterev et al. 2005; Li et al. 2018; Ni et al.
2018; Northington et al. 2011; Xu et al. 2010a; Yang et al.
2017a; Yin et al. 2015; Zhan et al. 2019; Zhang et al. 2016).
Moreover, in an in vitro setting, Nec-1 attenuated the neuronal
cell damage induced by various harmful agents, e.g., oaubain,
glutamate (Glu), N-methyl-D-aspartate (NMDA), 6-
hydroxydopamine (6-OHDA), rotenone, 1-methyl-4-
phenylpyridinium ion (MPP+), methamphetamine, aluminum
(Al), 24(S)-hydroxycholesterol, cholesterol, staurosporine,
and doxorubicin (Funakoshi et al. 2016; Ito et al. 2017;
Jantas et al. 2014a; Li et al. 2011; Wang et al. 2014; Wu
et al. 2015; Xiong et al. 2016; Xu et al. 2007; Yamanaka
et al. 2011; Zhang et al. 2013). It should be noted that the
protective effect of Nec-1 in the above studies was only par-
tial, suggesting the participation of other than necroptosis cell
death programs which can vary depending on the type of
neuronal injury as has already been shown by in vivo (ische-
mia, traumatic brain injury, spinal cord injury, retina injury)
and in vitro studies (e.g., Al-, iron-, 6-OHDA-, or β-amyloid-
induced neurotoxicity) (Askalan et al. 2015; Chinskey et al.
2014; Dai et al. 2013; Dong et al. 2012; Liu et al. 2014;
Rosenbaum et al. 2010; Qinli et al. 2013; Wu et al. 2015;
Xu et al. 2010a; Zhang et al. 2008). Consequently, a potential
synergistic effect has been proposed after combined treatment
with various cell death–specific inhibitors (Koshinuma et al.
2014; Xu et al. 2010a).
With the aim to extend a neuroprotective portfolio of Nec-
1, in the present study, we tested the hypothesis that this com-
pound protects human neuroblastoma SH-SY5Y cells against
the hydrogen peroxide (H2O2)- and 6-hydroxydopamine (6-
OHDA)-induced cell damage. The used experimental models
are widely accepted as cellular models of PD, where elevated
oxidative stress is a significant contributor to neuropathology
of this disease (Agholme et al. 2010; Castelli et al. 2019;
Cenini et al. 2019; Cheung et al. 2009; Miloso et al. 2004).
Based on our previous experiences, where neuronal differen-
tiation of SH-SY5Y cells could mask or limit a protective
effect of the tested agents (Jantas et al. 2014b, 2015b), we
hypothesized that Nec-1 will afford a greater protection to
undifferentiated (UN-SH-SY5Y) cells in comparison with
retinoic acid (RA)-differentiated (RA-SH-SY5Y) ones.
Although necrosis and/or apoptosis have been shown to par-
ticipate in the H2O2-induced cell damage in SH-SY5Y cells
(Chwastek et al. 2017; Jantas et al. 2015a), the involvement of
necroptosis has not been studied in detail, yet. In order to test a
potential interplay between apoptosis and necroptosis in our
models, we co-treated cells with the caspase-3 inhibitor, Ac-
DEVD-CHO, and Nec-1. Since previous studies showed neu-
roprotective effects of curcumin in various types of neuronal
cell damage (Mhillaj et al. 2019; Szczepanowicz et al. 2016)
and the involvement of both apoptosis and necroptosis inhibi-
tion has been suggested to be associated with the curcumin-
mediated protection (Dai et al. 2013; Wang et al. 2017; Xu
et al. 2019), we studied a potential synergism in neuroprotec-
tive effects of Nec-1 and curcumin (Curc) in UN- and RA-SH-
SY5Y cells. Next, we searched for putative mechanisms in-
volved in neuroprotection mediated by Nec-1 by measuring
the apoptotic markers (caspase-3 activity, AIF translocation),
calpain activity (145 kDa cleavage product of spectrin α II)
and lysosomal permeability (cathepsin D activity). For confir-
mation of the results in another type of neuronal cells, we
tested the effect of Nec-1 and its possible synergism with a
caspase inhibitor (Z-VAD-fmk) in the mouse hippocampal
HT-22 cells exposed to H2O2 or glutamate (Glu).
Materials and Methods
Drugs and Reagents
Dulbecco’s Modif ied Eagle ’s Medium (DMEM),
FluoroBrite™ DMEM, and fetal bovine serum (FBS) were
from Gibco (Invitrogen, Paisley, UK). The Cytotoxicity
Detection Kit and BM Chemiluminescence Western Blotting
Kit were from Roche Diagnostic (Mannheim, Germany).
Caspase-3 (Ac-DEVD-AMC) and cathepsin D (MOCA-Gly-
Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2)
fluorogenic substrates were obtained from Enzo Life Sciences
(NY, USA). Caspase-1 substrate (Ac-YVAD-AMC) and in-
hibitor (Ac-YVAD-CHO) were obtained from Promega
(Madison, WI, USA). Primary antibodies, anti-spectrin α II
(sc-48382), anti-AIF (sc-5586), anti-cathepsin D (sc-6486),
anti-GAPDH (sc-25778), and MW standards (sc-2035), and
secondary antibodies (sc-2004, sc-2005, sc-2020, and sc-
2030) were purchased from Santa Cruz Biotechnology Inc.
(CA, USA). All other reagents were from Sigma (Sigma-
Aldrich Chemie GmbH, Germany).
SH-SY5Y Cell Culture
The human SH-SY5Y neuroblastoma cells (ATCC, passages
5–20) were grown in DMEM supplemented with 10% (v/v)
heat-inactivated FBS and 100 units/ml of penicillin and
100 μg/ml of streptomycin as described previously (Jantas
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et al. 2015b). Cells were maintained at 37 °C in a saturated
humidity atmosphere containing 95% air and 5% CO2.
After reaching an 80% confluence, cells were counted with
a LUNA™ Automatic Cell Counter (Logos Biosystems,
Inc., Korea) and seeded at a density of 5 × 104, 2.5 × 105,
and 1 × 106 cells per well into 96-, 24-, and 6-well plates,
respectively. To obtain differentiated cells (RA-SH-
SY5Y), the cells were plated at a half of the densities men-
tioned above and cultured in medium supplemented with
retinoic acid (RA, 10 μM) for 6 days, during which the
culture medium was changed every 2 days. One day before
treatment, the culture medium for undifferentiated (UN-
SH-SY5Y) and RA-SH-SY5Y cells was replaced with
DMEM containing antibiotics and 1% (v/v) FBS.
HT-22 Cell Culture
The immortalized mouse hippocampal cell line HT-22 (pas-
sages 302–308; kind gift from Prof. Carsten Culmsee,
Institute of Pharmacology and Clinical Pharmacy, University
of Marburg, Germany) was grown in DMEM supplemented
with 10% (v/v) FBS and 1% (v/v) penicillin/streptomycin as
reported previously (Chwastek et al. 2017; Dolga et al. 2013).
After trypsinization, the cells were counted (LUNA™
Automatic Cell Counter, Logos Biosystems, Inc., Korea)
and seeded into 96-well plates at a density of 2 × 104 and
8 × 103 cells/well for H2O2- and Glu-induced cell damage,
respectively. Cells were maintained at 37 °C in a saturated
humidity atmosphere containing 95% (v/v) air and 5% (v/v)
CO2. One day before treatment, the culture medium for the
model of H2O2-evoked cell damage was replaced with
DMEM containing 1% (v/v) FBS and antibiotics. For Glu-
mediated oxytosis, the medium contained 10% (v/v) FBS
(Dolga et al. 2013).
Cell Treatment
The cells were pre-treated with various concentrations of Nec-
1 (1–40 μM) for 30 min followed by 24 h exposure to cell
damaging factors (H2O2, 6-OHDA, Glu). The chosen concen-
trations of Nec-1 were based on literature search and included
not active (< 1 μM) and RIP1-specific (> 3 μM) concentra-
tions (Degterev et al. 2008; Ito et al. 2017; Yamanaka et al.
2011; Yang et al. 2017b, 2019). For comparison of the Nec-1
effects with other protectants, the antioxidant, N-
acetylcysteine (NAC, 1 mM), and curcumin (Curc, 5 μM)
were used. The effective concentrations of H2O2 (0.25 and
0.5 mM for UN- and RA-SH-SY5Y cells, respectively;
1 mM for HT-22 cells) were established in our previous stud-
ies, in which this agent reduced cell viability by approximately
50% (Chwastek et al. 2017; Jantas et al. 2015a). The chosen
concentrations of 6-OHDA (0.1 and 0.2 mM for UN- and RA-
SH-SY5Y cells, respectively) or Glu (3 mM) were based on
the published literature (Cheung et al. 2009; Dolga et al. 2013;
Tieu et al. 1999). For mechanistic studies, inhibitors of calpain
(MDL28170; 10 μM)), cathepsin D (pepstatin A; PsA;
0.2 μM), caspase-3 (Ac-DEVD-CHO; 20 μM), caspase-1
(Ac-YVAD-CHO; 20 μM), and pan-caspase inhibitor (Z-
VAD-fmk; 20 μM) were used.
Nec-1 (100 mM), MDL28170 (10 mM), PsA (10 mM),
Ac-DEVD-CHO (10 mM), Ac-YVAD-CHO (10 mM), Z-
VAD-fmk (10 mM), and Curc (10 mM) stock solutions were
prepared in DMSO. The final solutions of the tested chemicals
were prepared in distilled water except for those of Curc
which were prepared in a mixture of dH2O and DMSO
(1:1). The H2O2 stock solutions (25 and 50 mM) were pre-
pared freshly from stabilized 30% (w/w) hydrogen peroxide
diluted in distilled water. The 6-OHDA stock solutions (10
and 20 mM) were prepared in distilled water immediately
before use. All agents were added to the culture medium at
the indicated concentrations under light limited conditions.
Each experimental set of the control cultures was supplement-
ed with the appropriate vehicles, and the solvent was present
in cultures at a final concentration of 0.1% (v/v).
Cell Viability Assay
Cell viability of UN- and RA-SH-SY5Yor HT-22 cells grow-
ing in 96-well plate format after 24 h of particular treatments
was quantified using a tetrazolium salt colorimetric assay with
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide (MTT) as described previously (Jantas et al. 2015a).
The data were normalized to the vehicle-treated cells (100%)
and expressed as a percent of the control ± SEM established
from 3 to 11 independent experiments with 5 replicates.
LDH Release Assay
The level of lactate dehydrogenase (LDH) released into
culture media from UN-, RA-SH-SY5Y, or HT-22 cells
after 24 h of treatment with Nec-1 and H2O2 was mea-
sured with Cytotoxicity Detection Kit (Roche) as de-
scribed previously (Jantas et al. 2015a). The data were
normalized to the vehicle-treated cells and expressed as
a percent of the control ± SEM from 3 to 11 independent
experiments with 5 replicates.
PI Staining and Flow Cytometry
To confirm the results obtained by biochemical cell viability/
toxicity assays, the SH-SY5Y and HT-22 cells were stained
with propidium iodide (PI) according to the method described
previously (Jantas et al. 2015a). A total of 1 × 104 cells were
analyzed using a BD FACS Canto II System and BD
FACSDiva™ v5.0.1 Software (BD Biosciences) in the fluo-
rescence channel for PerCP-Cy5-5-A (red fluorescence). The
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cells exhibiting loss of cell membrane integrity (PI positive)
represent necrotic and late apoptotic cells. Data are presented
as a percentage of PI-positive cells (± SEM) established from
3 to 5 independent experiments with 2 replicates.
CalceinAM/Hoechst 33342 Staining and Image
Analysis
In order to assess the morphology and viability of the UN- and
RA-SH-SY5Y cells after 9 and 18 h of treatment with Nec-1
(20 μM) and H2O2 (0.25 and 0.5 mM for UN- and RA-SH-
SY5Y cells, respectively), we performed live cell imaging by
employing a double staining of cells with cell-permeable
CalceinAM (marker of viable cells) and Hoechst 33342 (nu-
clei marker) dyes, as described previously (Fraczek-Szczypta
et al. 2018). The cells after labeling were placed in
FluoroBrite™ DMEM and were evaluated by using an
inverted fluorescence microscope (AxioObserver, Carl
Zeiss) with an excitat ion wavelength of 480 nm
(CalceinAM) and 355 nm (Hoechst 33342) equipped with a
black-white camera (Axio-CamMRm, Carl Zeiss). Five mi-
crophotographs for each panel (480 or 355 nm) were taken
for each tested group in duplicates for each endpoint (9 or
18 h) from 2 independent experiments. The numbers of pyk-
notic (condensed and/or fragmented) and healthy nuclei were
counted semi-manually from a 355-nm panel using
AxioVison software for each taken microphotograph, aver-
aged from 5 photos per well and the data are presented as
the mean ± SEM. To evaluate the impact of the tested agents
on neurite morphology, the neurite length was measured from
a 480-nm panel using Simple Neurite Tracer (an ImageJ add-
on software) as described previously (Fraczek-Szczypta et al.
2018). The lengths of ten random neurites per image, 3 images
per well, and 2 wells per experimental group were measured.
The data are presented as the mean neurite length ± SEM (in
μm) from 2 independent experiments.
Caspase-3 and Caspase-1 Activity Assays
The caspase-3 activity in UN- or RA-SH-SY5Y cells growing
in 6-well format and treated for 9 or 18 h with H2O2 and Nec-1
was measured using fluorogenic substrate Ac-DEVD-AMC
(50 μM) as described in detail previously (Jantas et al.
2015a). Caspase-3 inhibitor, Ac-DEVD-CHO (20 μM), was
used to verify the assay specificity. Moreover, we measured
caspase-3 and caspase-1 activities in RA-SH-SY5Y cells after
9 and 18 h of treatment with Nec-1 (20μM), Curc (5μM), and
H2O2 (0.5 mM). Caspase-1 activity was measured according
to a similar procedure as caspase-3 but with a different sub-
strate (Ac-YVAD-AMC, 50 μM) and inhibitor (Ac-YVAD-
CHO, 20 μM) as described previously (Jantas et al. 2018a).
The data (expressed as mean relative fluorescence units, RFU)
first were normalized to protein level (measured by BCA
method) and next calculated as a percent of vehicle-treated
cells and presented as the mean ± SEM from 2 to 3 separate
experiments with 2 repetitions each.
Cathepsin D Activity Assay
Cathepsin D activity in UN- and RA-SH-SY5Y cells treated
for 18 h with H2O2 and Nec-1 was measured using a fluo-
rometric method employing the fluorogenic substrate AMC-
Gly-Lys-Pro-Ile-Leu- Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-
NH2 as described previously (Chwastek et al. 2017). PsA
(0.2 μM) was used as a positive control for the assay.
Cathepsin D activity expressed in RFU first was calculated
per milligram of protein and next normalized to the vehicle-
treated cells; it is shown as the mean ± SEM from 3 to 4
independent experiments with 2 replicates.
Western Blot
ForWestern blot analysis of spectrin α II cleavage products in
whole cell lysates, UN- or RA-SH-SY5Y cells were cultured
in 6-well plates and pre-treated for 30 min with Nec-1
(20 μM) or calpain inhibitor MDL28170 (10 μM) followed
by 14 h exposure to H2O2 (0.25 and 0.5 mM for UN- and RA-
SH-SY5Y cells). For cathepsin D protein measurement (43
and 33 kDa) in whole cell lysates, UN- and RA-SH-SY5Y
cells were pre-treated with Nec-1 (20 μM) for 30 min follow-
ed by 18 h exposure to H2O2. For apoptosis inducing factor
(AIF) measurement in cytosolic fraction, UN-SH-SY5Y cells
were pre-treated with Nec-1 (1 and 20 μM) for 30 min follow-
ed by 14 h exposure to H2O2. The whole cell lysates and
cytosolic fractions (for measurement of AIF expression) were
prepared as previously described (Jantas et al. 2015a). Equal
amounts of protein were separated on 7% (w/v) (spectrin α II)
or 10% (w/v) (AIF, cathepsin D) SDS polyacrylamide gels
and transferred onto PVDF membranes. After blocking with
5% (w/v) nonfat milk in TBST, the membranes were incubat-
ed overnight with primary antibodies diluted at 1:500 (AIF,
cathepsin D) and 1:1000 (spectrin α II, GAPDH) in 1% (w/v)
nonfat milk. The amount of GAPDH was determined on the
same membrane on which the protein of interest was mea-
sured, by stripping and reprobing the membrane as described
previously (Jantas et al. 2015a). Data from 2 to 3 independent
experiments were normalized to the protein loading control
(GAPDH) and are expressed as fold of control (± SEM).
Statistical Analysis
Data were analyzed using the Statistica software (StatSoft
Inc., Tulsa, OK, USA). The analysis of variance (one-way
ANOVA) and post hoc Tukey’s test for multiple comparisons
were used to show statistical significance with assumed
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P < 0.05. For comparison of Nec-1 protective efficiency be-
tween UN- and RA-SH-SY5Y cells, a mean area under the
curve (AUC) was calculated and statistically analyzed with
(GraphPad Prism 7.04) with assumed P < 0.05. The unpaired
t test was also used for comparison of basal activities of
caspase-3 or cathepsin D in UN- and RA-SH-SY5Y cells.
Results
Neuroprotective Effects of Nec-1 Against H2O2-
and 6-OHDA-Induced Cell Damage in UN-
and RA-SH-SY5Y Cells: the Impact of Cell
Differentiation State
Twenty-four hours of treatment with Nec-1 at up to 40 μM
was safe for UN- or RA-SH-SY5Y cells as confirmed by cell
viability assay (Fig. 1a, d). Nec-1 (10–40 μM) attenuated the
cell damage induced by H2O2 in UN- and RA-SH-SHY5Y
cells (Fig. 1a, d) with a significantly higher protection (mea-
sured as a mean area under the curve (AUC)) mediated in the
former cell phenotype (AUC = 95.26 ± 5.74 and AUC =
44.82 ± 4.34 for UN- and RA-SH-SY5Y, respectively; t test,
P = 0.0009). It should be noticed that the neuroprotection me-
diated by the antioxidant, N-acetylcysteine (NAC, 1 mM),
was comparable with the effect of Nec-1 at its higher concen-
trations (20 and 40 μM) (Fig. 1). The neuroprotective action
of Nec-1 and NAC against H2O2 was confirmed by the LDH
release assay (Fig. 1b, e) and by PI staining in both cell phe-
notypes (Fig. 1c, f). Moreover, the beneficial effect of Nec-1
on cell viability was also morphologically confirmed by dif-
ferential interference contrast (DIC) images (Fig. 2) and by
CalceinAM staining (Fig. 3a). Additionally, we showed a sig-
nificant increase in the number of pyknotic nuclei after treat-
ment of UN-SH-SY5Y cells (after 9 h) and RA-SH-SY5Y
cells (after 9 and 18 h) with H2O2 which was not changed
by Nec-1 (20 μM) pre-treatment at any of the tested time
points (Fig. 3b). However, we observed that Nec-1 partially
protected the cells against H2O2-induced reduction in the
number of healthy nuclei which was observed after 18 h
but not after 9 h of treatment in both cell phenotypes (Fig.
3c). Next, we measured the impact of Nec-1 pre-treatment
on H2O2-evoked neurite shortening after 9 and 18 h of
treatment. In UN-SH-SY5Y cells, we found a significant
reduction in this parameter after 18 h of treatment with
H2O2 which was completely blocked by Nec-1 pre-treat-
ment (Fig. 3d, left panel). In the case of RA-SH-SY5Y
cells, the H2O2 evoked reduction in neurite length after 9
and 18 h of treatment which was significantly reduced by
Nec-1 (Fig. 3d, right panel).
Fig. 1 The effect of necrostatin-1 on H2O2-induced cell damage in UN-
and RA-SH-SY5Y cells. UN- and RA-SH-SY5Y cells (a–c and d–f,
respectively) were pre-treated for 30 min with necrostatin-1 (Nec-1; 1–
40 μM) followed by 24 h of treatment with H2O2 (0.25 and 0.5 mM for
UN- and RA-SH-SY5Y, respectively). As a positive control for the as-
says, we used antioxidant N-acetylcysteine (NAC, 1 mM) which was
given concomitantly with the cell damaging factor. a, d Results of cell
viability assessment in UN-(a) and RA-(d) SH-SY5Y cells measured by
the MTT reduction assay. Data were normalized to vehicle-treated cells
(control) and are presented as the mean ± SEM from 3 to 11 separate
experiments with 5 repetitions each. (b, e) Results of cell toxicity assess-
ment in UN-(b) and RA-(e) SH-SY5Y cells measured by the LDH release
assay. Data were normalized to vehicle-treated cells (control) and are
presented as the mean ± SEM from 4 to 11 separate experiments with 5
repetitions each. c, f Flow cytometry results of propidium iodide (PI)-
stained UN- (c) and RA (f) SH-SY5Y cells after 24 h of cell treatment.
Data are presented as the mean ± SEM of PI-positive cells from 3 to 5
independent experiments with 2 replicates. **P < 0.01 and ***P < 0.001
vs. vehicle-treated cells; #P < 0.05, ##P < 0.01, and ###P < 0.001 vs.
H2O2-treated cells
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Fig. 2 Representative DIC
(differential interference contrast)
images of UN-SH-SY5Y cells
treated for 24 h with necrostatin-1
(Nec-1, 20 μM) and hydrogen
peroxide (H2O2, 0.25 mM)
Fig. 3 a Representative microphotographs of UN- and RA-SH-SY5Y
cells double-stained with CalceinAM/Hoechst 33342 after 18 h of treat-
ment with necrostatin-1 (Nec-1; 20 μM) and hydrogen peroxide (H2O2;
0.25 and 0.5 mM for UN- and RA-SH-SY5Y cells, respectively). b, cAn
estimation of number of pyknotic (b) and healthy nuclei (c) fromHoechst
33342 staining. Nuclei showing bright blue florescence (condensed or
fragmented) staining were semi-manually counted and presented as the
mean percentage of pyknotic nuclei/all nuclei ± SEM or percentage of
healthy nuclei (normalized to control group) from two independent
experiments with two replicates. d Quantification of neurite length (in
μm) from CalceinAM staining using Simple Neurite Tracer (an ImageJ
add-on software). The lengths of ten random neurites per image, 3 images
per well, and 2 wells per experimental group were measured. The data are
presented as a mean neurite length ± SEM (in μm) from 2 independent
experiments. Statistical analysis was performed with one-way ANOVA
with Tukey’s post hoc test independently for each time point.
***P < 0.05, **P < 0.01, and ***P < 0.001 vs. vehicle-treated cells;
#P < 0.05 vs. H2O2-treated cells
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To confirm the neuroprotective potential of Nec-1 in
SH-SY5Y cells, we also used another oxidative stress–
based model employing 6-OHDA. We observed a partial
protection mediated by Nec-1 in UN-SH-SY5Y (20 and
40 μM) and RA-SH-SY5Y (40 μM) cells (Table 1)
against 6-OHDA-induced cell damage with a slight ten-
dency towards a higher protection in the former cell type
(AUC = 24.64 ± 4.15 and AUC = 14.11 ± 2.91 for UN- and
RA-SH-SY5Y, respectively; t test, P = 0.0968).
Neuroprotective Effects of Nec-1 Against Oxidative
Stress–Induced Cell Damage in HT-22 Cells
Twenty-four hours of treatment with Nec-1 at up to 40 μM
was safe for HT-22 cells (Fig. 4a). Nec-1 attenuated the HT-22
cell damage induced byH2O2 at concentrations of 20μM, 20–
40 μM, and 10–40 μM in the MTT reduction, LDH release,
and PI staining assays, respectively (Fig. 4a–c). Moreover,
Nec-1 significantly attenuated the Glu-evoked cell damage
in the concentration range 10–40 μM and that effect was sim-
ilar to NAC-mediated protection (Fig. 4d).
The Effect of Combined Treatment with Nec-1
and Caspase-3 Inhibitor in UN- and RA-SH-SY5Y Cells
Since in our study we used the cell damage models con-
nected with induction of apoptosis, and on the other hand
we observed protective effects of necroptosis inhibitor
Nec-1, we have speculated that combination of a
caspase-3 inhibitor with Nec-1 could increase the extent
of protection when compared with their effects when giv-
en separately. In UN- and RA-SH-SY5Y cells, we
observed a similar range of protection mediated by Nec-
1 and Ac-DEVD-CHO against H2O2-evoked cell damage
when drugs were administrated separately which has not
been changed after combined treatment with both protec-
tants (Fig. 5a, b). We obtained similar results in the model
of 6-OHDA-induced UN-SH-SY5Y cell damage (Fig. 6a).
In RA-SH-SY5Y cells, we also observed that Nec-1 at-
tenuated the cell injury evoked by 6-OHDA and that this
effect was not changed by combined treatment with
caspase-3 inhibitor. The latter compound was not protec-
tive in this cell phenotype (Fig. 6b).
The Effect of Combined Treatment with Nec-1
and Curcumin in UN- and RA-SH-SY5Y Cells
In UN-SH-SY5Y cells, curcumin (5 μM) and Nec-1 (40 μM)
were protective against H2O2- or 6-OHDA-evoked cell dam-
age to the same extent when given separately or in combina-
tion (Figs. 5c and 6c). However, in RA-SH-SY5Y we ob-
served a significantly higher protection of combined treatment
with both agents when compared with the effect of each com-
pound given alone in the model of H2O2-induced cell damage
(Fig. 5d) but not in 6-OHDA one (Fig. 6d). It should be noted
that Curc (5 μM) was not protective in RA-SH-SY5Y cells
against H2O2- or 6-OHDA-evoked cell damage when given
alone (Figs. 5d and 6d).
The Effect of Combined Treatment with Nec-1
and Caspase Inhibitor in HT-22 Cells
The H2O2-evoked HT-22 cell damage was attenuated by
Nec-1 (20 μM) but not by the caspase inhibitor, Z-VAD-
fmk (20 μM) (Fig. 7a). Unexpectedly, the latter agent
inhibited the Nec-1-mediated protection (Fig. 7a).
Similar results we found in the model of Glu-induced cell
damage (Fig. 7b).
Neuroprotection Mediated by Nec-1 in SH-SY5Y Cells
Is Not Connected with Caspase-3 Inhibition
Since our previous studies showed an involvement of caspase-
3 activation in detrimental effects of H2O2 in SH-SY5Y cells
(Chwastek et al. 2017; Jantas et al. 2015a), and on the other
hand there are data showing the effect of Nec-1 on caspase-3
activity in some models of neuronal cell injury (Wang et al.
2014; Yang et al. 2017a, b), we decided to check the effect of
Nec-1 on caspase-3 activity in our study. We showed an acti-
vation of caspase-3 in the model of H2O2-evoked cell damage
in UN- and RA-SH-SY5Y cells which has been totally
prevented by caspase-3 inhibitor Ac-DEVD-CHO but was
not affected by Nec-1 (1–20 μM) (Table 2). We further con-
firmed a lack of involvement of caspase-3 inhibition in neu-
roprotection mediated by Nec-1 against H2O2 byWestern blot
Table 1 The effect of necrostatin-1 on 6-OHDA-induced cell damage
in UN- and RA-SH-SY5Y cells
UN-SH-SY5Y RA-SH-SY5Y
Control 99.9 ± 0.1 100.0 ± 0.0
6-OHDA 62.8 ± 0.6*** 68.6 ± 0.2***
+ Nec-1 20 72.0 ± 2.6***,# 70.2 ± 2.0***
+ Nec-1 40 78.2 ± 5.6***, ## 81.2 ± 3.8**, #
+ NAC 81.4 ± 4.7***, ### 83.2 ± 4.0**, #
UN- and RA-SH-SY5Y cells were pre-treated for 30 min with
necrostatin-1 (Nec-1; 20 and 40 μM) followed by 24 h of treatment with
6-hydroxydopamine (6-OHDA, 0.1 and 0.2 mM for UN- and RA-SH-
SY5Y cells, respectively)
An antioxidant N-acetylcysteine (NAC, 1 mM) was given to cells con-
comitantly with 6-OHDA. The MTT reduction assay was employed for
cell viability assessment
Data were normalized to the vehicle-treated cells and are presented as the
mean ± SEM from 4 separate experiments with 5 repetitions each
**P < 0.01 and ***P < 0.001 vs. vehicle-treated cells
#P < 0.05, ##P < 0.01, and ##P < 0.001 vs. 6-OHDA-treated cells
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analysis of 120 kDa spectrin α II breakdown product which is
specifically cleaved by caspases (Fig. 8a, b).
Looking for possible mechanisms responsible for synergis-
tic effect of Nec-1 and curcumin against the H2O2-induced
cell damage, we checked caspase-3 and caspase-1 activities
in RA-SH-SY5Y cells. The H2O2-induced caspase-3 activity
after 18 h of treatment was not attenuated by Curc (5 μM)
alone or in combination with Nec-1 (20μM) (data not shown).
However, we found an increase in caspase-1 activity after 18
but not after 9 h of treatment of RA-SH-SY5Y cells with H2O2
(0.5 mM) which was significantly attenuated by combined
treatment with Nec-1 and Curc, but not when the agents were
given separately (Table 3).
Neuroprotection Mediated by Nec-1 Is Not Connected
with Inhibition of Calpains or Caspase-3-Independent
Mechanism Engaging AIF Translocation
Since calpains, calcium-dependent intracellular proteases,
have been reported to participate in the mechanisms of
H2O2-evoked neuronal cell damage (Chwastek et al. 2017;
Jantas et al. 2015a), we measured by Western blot the protein
level of 145 kDa spectrin α II breakdown product, which is
specifically cleaved by calpains. Our data showed a signifi-
cant increase in calpain activity after 14 h treatment with H2O2
in UN- and RA-SH-SY5Y, which has been attenuated by
calpain inhibitor MDL28170 (10 μM) but not influenced by
Nec-1 (20 μM) (Fig. 8a, b).
Based on our previous findings where we showed an en-
gagement of caspase-3 independent mechanism engaging AIF
translocation in the model of H2O2-evoked cell damage in
UN-SH-SY5Y cells (Jantas et al. 2015a), and on the other
hand, there are data showing a connection between AIF trans-
location and necroptosis induction (Bollino et al. 2015; Ji et al.
2011; Xu et al. 2010b, 2016), we decided to study the effect of
Nec-1 (20 μM) on cytosolic AIF protein level. We observed
almost twofold increase in cytosolic AIF level after 14 h of
treatment of UN-SH-SY5Y cells with H2O2 (0.25 mM) which
confirms our previous data (Jantas et al. 2015a); however, this
effect was not changed by Nec-1 (20 μM) (Fig. 8c).
Fig. 4 The effect of necrostatin-1 on H2O2- (a–c) or glutamate- (Glu, d)
induced cell damage in hippocampal HT-22 cells. The cells were pre-
treated for 30 min with necrostatin-1 (Nec-1; 1–40 μM) followed by
24 h of treatment with H2O2 (1 mM) or Glu (3 mM). As a positive control
for the assays, we used antioxidant N-acetylcysteine (NAC, 1 mM)which
was given concomitantly with the cell damaging factors. a, d Results of
cell viability assessment in the model of cell damage induced by H2O2-
(a) and Glu (d) measured by the MTT reduction assay. Data were nor-
malized to vehicle-treated cells (control) and are presented as the mean ±
SEM from 3 to 10 separate experiments with 5 repetitions each. b Results
of cell toxicity assessment in HT-22 cell exposed to H2O2 and Nec-1
measured by the LDH release assay. Data were normalized to vehicle-
treated cells (control) and are presented as the mean ± SEM from 3 to 5
separate experiments with 5 repetitions each. c Flow cytometry results of
propidium iodide (PI)-stained HT-22 cells after 24 h of cell treatment with
H2O2 and Nec-1. Data are presented as the mean ± SEM of PI-positive
cells from 3 to 4 independent experiments with 2 replicates. *P < 0.05,
**P < 0.01, and ***P < 0.001 vs. vehicle-treated cells; #P < 0.05,
##P < 0.01, and ###P < 0.001 vs. H2O2- or Glu-treated cells
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Neuroprotection Mediated by Nec-1
Against H2O2-Evoked Cell Damage in UN-
and RA-SH-SY5Y Cells Is Connected with Cathepsin D
Inhibition
Based on our previous findings where we showed an in-
volvement of cathepsin D activation in the cell damaging
effect of H2O2 in RA-SH-SY5Y cells (Chwastek et al.
2017), we decided to check if the inhibition of this enzyme
could be involved in the neuroprotective effect of Nec-1.
We observed an almost three- and twofold increase in ca-
thepsin D activity after 18 h of treatment with H2O2 (0.25
and 0.5 mM for UN- and RA-SH-SY5Y cells, respectively)
which was completely blocked by cathepsin D inhibitor,
pepstatin A (0.2 μM) (Fig. 9a, b). Nec-1 significantly at-
tenuated the H2O2-evoked cathepsin D activity at concen-
trations of 10–20 μM and 20–40 μM for UN- and RA-
SHSY5Y cells, respectively (Fig. 9a, b). We also checked
the cathepsin D protein level by WB method; however, we
did not find any significant changes in 43 and 33 kDa
cathepsin D forms after 18 h of treatment with H2O2 and
Nec-1 in UN- and RA-SH-SY5Y cells (Fig. 9c, d).
Next, we compared the level of protection mediated by
Nec-1 (20 μM) or PsA (0.2 μM) when given separately or
in combination in the model of H2O2-evoked cell death in
UN-SH-SY5Y cells. The protection mediated by Nec-1 was
comparable with the effect of PsA which was not changed
after combined treatment with both inhibitors as estimated
by the MTT reduction and LDH release assays (Table 4).
Discussion
The present study confirmed that SH-SY5Y cell culture is a
reliable in vitro model for studying the mechanism of neuro-
toxicity, and that undifferentiated SH-SY5Y cells are more
prone to the effects of cell damaging compounds than the
differentiated ones (Chwastek et al. 2017; Jantas et al.
2014b, 2015b, 2018b; Wenker et al. 2010). We found that
30 min pre-treatment of the SH-SY5Y cells with Nec-1 in a
wide range of micromolar concentrations attenuated but not
totally prevented toxic effects of H2O2 or 6-OHDA suggesting
that necroptosis could be only one of several activated cell
death signaling pathways following exposure of the cells to
the above-mentioned toxic agents. Indeed, it was reported that
caspase-3-dependent apoptosis and necrosis were also in-
volved in the mechanism of H2O2 neurotoxicity (Chwastek
et al. 2017; Cole and Perez-Polo 2002; Jantas et al. 2015a;
Fig. 5 The effect of combined treatment with necrostatin-1 (Nec-1) and
caspase-3 inhibitor (Ac-DEVD-CHO) (a, b) or Nec-1 and curcumin
(Curc) against the hydrogen peroxide-induced cell damage in UN- (a,
c) and RA- (b, d) SH-SY5Y cells. The cells were pre-treated for 30 min
with Nec-1 (20μM) andAc-DEVD-CHO (20μM) orNec-1 (20μM) and
Curc (5 μM) alone or in combination followed by 24 h of treatment with
H2O2 (0.25 mM and 0.5 mM for UN- and RA-SH-SY5Y cells). Cell
viability was estimated by the MTT reduction assay, and data were nor-
malized to vehicle-treated cells (control) and are presented as the mean ±
SEM from 3 separate experiments with 5 repetitions each. *P < 0.05 and
***P < 0.001 vs. vehicle-treated cells; #P < 0.05 and ###P < 0.001 vs.
H2O2-treated cells;
&P < 0.05 and &&&P < 0.001 vs. H2O2 + Nec-1 +
Curc-treated cells
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Park et al. 2016), which was also confirmed in our present
study by measurement of apoptotic and necrotic markers,
caspase-3 activity, and PI staining, respectively (Fig. 1,
Table 2). We also found protection mediated by Nec-1 in
another model of oxidative stress (6-OHDA) in UN- and
RA-SH-SY5Y cells (Table 1), which confirms previous find-
ings from PC12 cells (Wu et al. 2015), but that effect was
relatively smaller than against H2O2. It could probably be
explained by the predominant role of apoptotic processes in
6-OHDA-induced cytotoxicity in SH-SY5Y cells (No et al.
2010; Park et al. 2014). Our study showed that the protective
effect of Nec-1 against H2O2 was quantitatively similar to the
effect of the specific caspase-3 inhibitor (Ac-DEVD-CHO) in
both SH-SY5Y cell phenotypes, although no synergy after
concomitant treatment with the both agents could be observed
(Figs. 5a, b and 6a). Similar results were obtained in the 6-
OHDA model but only in UN-SH-SY5Y cells, since in dif-
ferentiated ones we did not find protection by a caspase-3
inhibitor (Fig. 6b). The above findings suggest a link between
apoptotic and necroptotic machinery at least in SH-SY5Y
cells exposed to oxidative stress stimulus since in another cell
damage model of neuroblastoma cells (induced by
stenodactylin) there was a complete prevention of cell death
by combined treatment with caspase inhibitor (Z-VAD-fmk)
plus catalase or Nec-1 (Polito et al. 2016). Our data from SH-
SY5Y cells are in contrast to results of previous study where
Nec-1 (40 μM) but not pan-caspase inhibitor (Z-VAD-fmk)
attenuated cell damage induced by H2O2 in neuroblastoma
SK-N-SH cells (Lee et al. 2011). Similar results we obtained
in HT-22 cells where Nec-1 but not the caspase inhibitor was
protective against H2O2 or Glu-induced cell damage (Fig. 4)
suggesting a cell-specific mechanisms of Nec-1 protective ac-
tion. Moreover, in HT-22 cells, Z-VAD-fmk inhibited protec-
tion induced by Nec-1 after concomitant treatment which con-
firms data obtained byXu et al. (2007) at least for the model of
Glu-evoked oxytosis. However, we found an opposite effect
in the H2O2-induced cell death model, since in the paper by
Xu et al. (2007) they did not show Nec-1-elicited protection
against oxidative stress (H2O2 or menadione)-induced cell
damage. Nec-1 was also not protective against H2O2-induced
cell damage in oligodendrocyte precursors (Kim et al. 2010).
It is not excluded that at a shorter time of exposure to oxidative
stressors (8 h) used by Xu et al. (2007) the mechanisms of cell
death of HT-22 cells are more necrotic and thus not affected by
Nec-1, whereas in our model with 24 h of treatment, there was
the situation of necroptosis induction which could be
prevented by Nec-1. Although there are some reports showing
the involvement of autophagy in the H2O2-evoked cell dam-
age of SH-SY5Y cells (Castino et al. 2010, 2011), our unpub-
lished data showed no autophagy induction after hydrogen
peroxide treatment in UN-SH-SY5Y cells (at least when mea-
sured byWB analysis of LC3 II, p62, and Beclin-1 levels after
Fig. 6 The effect of combined treatment with necrostatin-1 (Nec-1) and
caspase-3 inhibitor (Ac-DEVD-CHO) (a, b) or Nec-1 and curcumin
(Curc) (c, d) against the 6-OHDA-induced cell damage in UN- (a, c)
and RA- (b, d) SH-SY5Y cells. The cells were pre-treated for 30 min
with Nec-1 (20μM) andAc-DEVD-CHO (20μM) orNec-1 (20μM) and
Curc (5 μM) alone or in combination followed by 24 h of treatment with
6-OHDA (0.1 and 0.2 mM for UN- and RA-SH-SY5Y cells, respective-
ly). Cell viability was estimated by the MTT reduction assay, and data
were normalized to vehicle-treated cells (control) and are presented as the
mean ± SEM from 3 separate experiments with 5 repetitions each.
*P < 0.05, **P < 0.01, and ***P < 0.001 vs. vehicle-treated cells;
#P < 0.05, ##P < 0.01, and ###P < 0.001 vs. H2O2-treated cells
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9, 18, or 24 h after cell treatment). The differences between
our results and Castino et al. (2010, 2011) findings could be
explained by different concentrations of H2O2 used
(250 μM and 50–100 μM, respectively) as well as culture
medium content (DMEM with high glucose with 1% FBS
vs. 50% minimal essential medium and 50% F12 nutrient
medium supplemented with 10% FBS, respectively). All
these factors could significantly influence the type of in-
duced cell death program after the same stimulus. Since
autophagy inhibition has been linked with Nec-1 neuro-
protection mediated against 6-OHDA-evoked cell damage
in rat PC12 cells (Wu et al. 2015), it is not excluded that
this process could be also engaged in the protection
against this neurotoxin in human SH-SY5Y cells.
In our study, we showed for the first time that neuroprotec-
tion mediated by Nec-1 was higher in undifferentiated than
RA-differentiated SH-SY5Y cells at least when AUC values
in cell viability assay were compared. This effect was more
pronounced in the model of H2O2-induced cell damage than
6-OHDA-induced injury. Moreover, the non-specific apopto-
sis and necroptosis inhibitor curcumin significantly augment-
ed beneficial effect of Nec-1 against H2O2, though in RA-SH-
SY5Y cells only. The above facts suggest that the interplay
between necroptosis and apoptosis depends on the differenti-
ation state of the cell culture and that some mechanisms of
Nec-1 neuroprotective action could be masked by differentia-
tion of cells with retinoic acid (e.g., activation of PI3-K/Akt
and MAPK/ERK1/2 pro-survival pathways) (Cheung et al.
2009; Lopes et al. 2010; Wenker et al. 2010). The higher basal
and stimulated caspase-3 activity in UN-SH-SY5Y cells,
shown by us, also supports anti-apoptotic phenotype of RA-
SH-SY5Y cells. It is also corroborated by our observation of
the lack of neuroprotective effect of a caspase-3 inhibitor or
Fig. 7 The effect of combined treatment with necrostatin-1 (Nec-1) and
pan-caspase inhibitor (Z-VAD-fmk) against the H2O2- (a) and glutamate-
(Glu, b) induced cell damage in HT-22 cells. The cells were pre-treated
for 30 min with Nec-1 (20 μM) and Z-VAD-fmk (20 μM) alone or in
combination followed by 24 h of treatment with H2O2 (1 mM) or Glu
(3 mM). Cell viability was estimated by the MTT reduction assay, and
data were normalized to vehicle-treated cells (control) and are presented
as the mean ± SEM from 3 to 7 separate experiments with 5 repetitions
each. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. vehicle-treated cells;
#P < 0.05 and ###P < 0.001 vs. H2O2- or Glu-treated cells;
&P < 0.05 and
&&&P < 0.001 vs. H2O2 + Nec-1 or Glu + Nec-1-treated cells
Table 2 The effect of necrostatin-
1 on hydrogen peroxide-induced
caspase-3 activity in UN- and
RA-SH-SY5Y cells
UN-SH-SY5Y RA-SH-SY5Y RA-SH-SY5Y
9 h 9 h 18 h
Control 100.0 ± 8.0 100.0 ± 2.7 100.0 ± 5.8
Nec-1 20 95.9 ± 0.3 109.3 ± 5.2 119.8 ± 5.9
H2O2 753.8 ± 20.5 *** 229.6 ± 18.9 *** 487.9 ± 44.9 ***
+ Nec-1 1 854.7 ± 31.5 *** 236.9 ± 5.8 ** 668.0 ± 64.3 ***
+ Nec-1 10 746.1 ± 39.2 *** 252.9 ± 12.2 *** 568.1 ± 52.8 ***
+ Nec-1 20 760.9 ± 19.8 *** 271.9 ± 8.2 *** 520.1 ± 27.5 ***
+ Ac-DEVD-CHO 33.5 ± 1.1 ### 24.0 ± 14.0 ### 19.9 ± 8.9 ###
UN- and RA-SH-SY5Y cells were pre-treated for 30 min with necrostatin-1 (Nec-1; 1–20 μM) followed by 9 or
18 h of treatment with H2O2 (0.25 and 0.5 mM for UN- and RA-SH-SY5Y, respectively)
As a positive control for the assay we used Ac-DEVD-CHO (20 μM), an inhibitor of caspase-3 which was given
30 min before the cell damaging factor
Data were normalized to vehicle-treated cells (control) and are presented as the mean ± SEM from 3 separate
experiments with 2 repetitions each
**P<0.01 and ***P < 0.001 vs. vehicle-treated cells
###P < 0.001 vs. H2O2-treated cells
Neurotox Res (2020) 37:525–542 535
curcumin in RA-SH-SY5Y cells against 6-OHDA-evoked
cell damage, which is the cell death model connected rather
with apoptotic than necrotic processes that are saturated after
differentiation with RA (Cheung et al. 2009; No et al. 2010;
Park et al. 2014). Our results obtained in UN-SH-SY5Y cells
confirmed previous findings on neuroprotective effect of
curcumin which could be mediated by its antioxidant, anti-
apoptotic, and anti-inflammatory mechanisms (Mhillaj et al.
2019; Sang et al. 2018; Uğuz et al. 2016).
The main finding of this study is the first observation that
Nec-1 attenuating effect on hydrogen peroxide-induced SH-
SY5Y cell damage is associated with the inhibition of cathep-
sin D (Fig. 9) but not caspase-3 or calpain activities (Table 2,
Fig. 8a, b). Cathepsin D is a lysosomal protease which plays a
pivotal role in protein catabolism, having an impact on several
pathophysiological processes, such as organ development,
neurodegeneration, or cancer (Follo et al. 2007). Elevated
ROS level could increase permeability of lysosomes and thus
can promote release of cathepsins into cytoplasm leading to
activation of various cell death programs (e.g., apoptosis)
(Castino et al. 2007; Follo et al. 2007). Human cathepsin D
is synthesized as a precursor of approximately 53 kDa that is
processed by proteolysis first into an intermediate single-chain
of 48 kDa and eventually into the mature double-chain form
(Crabtree et al. 2014; Follo et al. 2007). It should be noted that
in our study, the inhibitory action of Nec-1 on cathepsin Dwas
present in UN- and RA-SH-SY5Y cells and the basal activity
Fig. 8 a, b The effect of necrostatin-1 (Nec-1) on the H2O2-induced
145 kDa and 120 kDa spectrin α II breakdown products in UN- and
RA-SH-SY5Y cells, which are specifically cleaved by calpains and
caspases, respectively. Cells were pre-treated for 30 min with Nec-1
(20 μM) or calpain inhibitor MDL28170 (10 μM), followed by 14 h of
treatment with H2O2 (0.25 and 0.5 mM for UN- and RA-SH-SY5Y cells,
respectively). c The effect of Nec-1 on the H2O2-induced increase in
cytosolic AIF (apoptosis inducing factor) level. The UN-SH-SY5Y cells
were pre-treated for 30 min with Nec-1 (20 μM) followed by 14 h of
treatment with H2O2 (0.25 mM). a–c Histograms show the quantified
Western blot results from duplicate determinations in 2–3 independent
experiments which were normalized to the protein loading control
(GAPDH) and are expressed as fold of the control ± SEM. *P < 0.05,
**P < 0.01, and ***P < 0.001 vs. vehicle-treated cells; #P < 0.05 vs.
H2O2-treated cells
Table 3 The effect of necrostatin-1 and curcumin alone and in combi-
nation against the hydrogen peroxide-induced caspase-1 activity in RA-
SH-SY5Y cells
9 h 18 h
(% control) (% control)
Control 100.0 ± 0.8 100.0 ± 6.4
H2O2 93.7 ± 8.3 171.5 ± 15.8 ***
+ Nec-1 107.6 ± 3.7 143.6 ± 9.5 *
+ Curc 114.8 ± 8.1 135.1 ± 3.9
+ Nec-1 + Curc 116.3 ± 2.6 128.8 ± 5.5 #
+ Inh cas-1 73.9 ± 6.8 42.6 ± 4.3 **,###
RA-SH-SY5Y cells were pre-treated for 30 min with necrostatin-1 (Nec-
1; 20μM) followed by 24 h of treatment with curcumin (Curc, 5 μM) and
H2O2 (0.5 mM)
As a positive control for the assay we used Ac-YVAD-CHO (20 μM), an
inhibitor of caspase-1 which was given 30 min before the cell damaging
factor
Data were normalized to the vehicle-treated cells and are presented as the
mean ± SEM from 2 separate experiments with 2 repetitions each
*P < 0.05, ***P < 0.01, and ***P < 0.001 vs. vehicle-treated cells
#P < 0.05 and ###P < 0.001 vs. H2O2-treated cells
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of cathepsin D as well as expression of its double-chain form
(43 and 33 kDa) did not differ between both cell phenotypes
(Fig. 9). Moreover, the range of protection mediated by the
cathepsin D inhibitor, pepstatin A, was similar to the effect of
Nec-1 (Table 4) suggesting an interplay between necroptosis
and lysosomal-permeability-induced cell death and a shared
mechanism of action for both inhibitors. To our knowledge,
there was only one report showing that necroptotic pathway
was augmented by the activation of cathepsin D; however,
that paper concerned activation of innate antiviral immune
response in A549 cells (Wang et al. 2016). However, there
are some reports linking Nec-1-mediated protection with its
inhibitory effect on cathepsin B activity as has been shown in
hippocampal neuronal programmed necrosis induced by
ischemia/reperfusion injury (Yin et al. 2015) or in PC12 cells
exposed to 6-OHDA (Wu et al. 2015). The activation of var-
ious forms of cathepsins seems to be specific for cell damag-
ing factor and/or cell type since the activation of cathepsin D
but not cathepsin B was observed in PC12 cells exposed to
H2O2 (Lee et al. 2007) which was also confirmed in our pre-
vious study with SH-SY5Y cells (Chwastek et al. 2017). The
active role of cathepsin D in oxidative stress–induced cell
death in neuroblastoma cells was shown by siRNA-mediated
downregulation of the enzyme, besides using PsA (Castino
et al. 2008, 2010, 2011). One could doubt about cell perme-
ability to PsA and efficient cathepsin D inhibition in lyso-
somes (Nicotra et al. 2010); however, this inhibitor has been
used for many years by various research groupsmostly in cell-
based system (Chahory et al., 2010; Crabtree et al. 2014; Follo
Fig. 9 a, b The effect of necrostatin-1 (Nec-1) on H2O2-induced cathep-
sin D activity in UN- (a) and RA (b) SH-SY5Y cells. The cells were pre-
treated for 30 min with Nec-1 (1–40 μM) or pepstatin A (PsA; 0.2 μM)
followed by 18 h of treatment with H2O2 (0.25 and 0.5 mM for UN- and
RA-SH-SY5Y cells, respectively). Data from duplicate determinations in
3–4 independent experiments were normalized to the protein level and are
expressed as percentages of the control ± SEM. c, d The effect of
necrostatin-1 (Nec-1) on H2O2-induced cathepsin D expression in UN-
(c) and RA- (d) SH-SY5Y cells. The cells were pre-treated for 30 min
with Nec-1 (20 μM) followed by 18 h of treatment with H2O2 (0.25 and
0.5 mM for UN- and RA-SH-SY5Y cells, respectively). Expression of 43
and 33 kDa forms of cathepsin D was done by Western blot method.
Histograms show the quantified WB results from duplicate determina-
tions in 2 independent experiments which were normalized to the protein
loading control (GAPDH) and are expressed as fold of the control ± SEM
Table 4 The effect of necrostatin-1 and pepstatin A alone and in com-
bination against the hydrogen peroxide-induced cell damage in UN-SH-
SY5Y cells
Cell viability LDH release
(% control) (% control)
Control 100.0 ± 9.9 100.2 ± 6.4
H2O2 60.6 ± 4.3 *** 358.3 ± 17.2 ***
+ Nec-1 90.3 ± 4.1 ## 277.2 ± 14.1 ***, ##
+ PsA 88.9 ± 3.7 # 271.8 ± 10.2 ***, ###
+PsA + Nec-1 89.1 ± 3.3 # 280.3 ± 16.2 ***, ##
UN-SH-SY5Y cells were pre-treated for 30 min with necrostatin-1 (Nec-
1; 20 μM) and pepstatin A (PsA; 0.2 μM) alone and in combination
followed by 24 h of treatment with H2O2 (0.25 mM)
The MTT reduction and LDH release assays were employed for cell
viability and toxicity assessments, respectively
Data were normalized to the vehicle-treated cells and are presented as the
mean ± SEM from 3 separate experiments with 5 repetitions each
***P < 0.001 vs. vehicle-treated cells
#P < 0.05, ##P < 0.01, and ###P < 0.001 vs. H2O2-treated cells
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et al. 2007; Kanamori et al. 1998). Since cathepsin D has also
physiological functions, maybe for neuroprotection strategies
it will be more relevant to inhibit activity of this enzyme only
when it is pathologically released from lysosomes. One could
ask what mechanisms are responsible for induction of cathep-
sin D activity by H2O2 and inhibitory effect of Nec-1 on this
parameter. By WB analysis of two mature cathepsin D forms
(43 and 33 kDa), we excluded the possibility of the impact of
H2O2 and Nec-1 on expression of this protein (Fig. 9c, d). It is
likely that Nec-1 could chemically interact with the active site
of cathepsin D in a similar way as PsA do; however, we did
not find relevant reports. The only study regarding Nec-1
specificity tested its effect on the panel of 98 kinases and
found that Nec-1 < 30 μM inhibited only RIP1 (Biton and
Ashkenazi 2011). It will be also interesting to study in the
future whether curcumin engages cathepsin D inhibition in
its protective action against oxidative stress.
Among other possible mechanisms which could be in-
volved in Nec-1-mediated neuroprotection in SH-SY5Y cells,
we excluded inhibition of caspase-3 (Table 2), calpains (Fig.
8a, b), or AIF translocation (Fig. 8c) although all of themwere
induced by H2O2. Some reported data pointed to a connection
between AIF translocation and necroptosis induction (Bollino
et al., 2015; Ji et al. 2011; Xu et al. 2010b, 2016) and that Nec-
1 inhibited the nuclear translocation of AIF in the model of
Glu-evoked cell damage (Xu et al. 2007). Previously, we de-
scribed a caspase-3-independent mechanism engaging AIF
translocation in the model of H2O2-evoked cell damage in
UN-SH-SY5Y cells (Jantas et al. 2015a). Although the pres-
ent data confirmed AIF translocation in the oxidative stress
model, it was not affected by Nec-1 treatment. It should be
underlined that we observed the impact of curcumin on H2O2-
induced caspase-3 activation in UN-SH-SY5Y cells (data not
shown) which could be a result of its ROS-scavenging activity
(Szczepanowicz et al. 2016) and consequently inhibition of
apoptotic processes. It should be mentioned that once
translocated into the cytosol upon oxidative stress–induced
permeabilization of the lysosomes (H2O2 for 30 min), cathep-
sin D was shown to act on Bax to induce apoptosis in human
neuroblastoma cells (Castino et al. 2007). However, this phe-
nomenon is unlikely to be implicated in Nec-1 neuroprotec-
tive action against H2O2-evoked cell damage since under our
experimental conditions cathepsin D was activated relatively
late (after 18 h, Chwastek et al. 2017) whereas apoptotic
changes occurred earlier (9 and 18 h) and were not changed
by Nec-1 (Fig. 3b, c, Table 2). It is interesting that we found
the influence of Nec-1 on H2O2-evoked neurite shortening
(Fig. 3d) which confirms in vivo findings on participation of
necroptosis in axonal degeneration and suggests a possible
therapeutic intervention by its inhibition by Nec-1 (Arrázola
et al. 2019). While this effect was observed in UN-SH-SY5Y
at the late stage (18 h), in RA-SH-SY5Y cells, it was present at
both studied time points (9 and 18 h) (Fig. 3d). The mecha-
nisms by which Nec-1 interfere with H2O2-evoked reduction
Fig. 10 A schematic illustration
of possible mechanisms by which
the necrostatin-1 (Nec-1)
mediates neuroprotection against
the H2O2-induced cell damage in
undifferentiated (UN-) and
retinoic acid (RA)-differentiated
SHSY5Y cells. Cathepsin D
inhibition, but not caspase-3,
calpain or AIF (apoptosis
inducing factor) translocation
inhibition, is proposed as a
candidate mechanism associated
with neuroprotection mediated by
Nec-1 in oxidative stress (H2O2)-
evoked cell damage. Ac-
DEVD—Ac-DEVD-CHO, an
inhibitor of caspase-3; MDL—
MDL28170, an inhibitor of
calpains; CD—cathepsin D;
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of neurites length are unknown yet and should be investigated
in the future. It should be underlined that RA-differentiated
cells are more suitable for monitoring of neurite outgrowth
than undifferentiated ones (Lee et al. 2015; Miloso et al.
2004). Finally, we confirmed in RA-SH-SY5Y cells the
H2O2 potency to induce ICE-like protease, caspase-1 activity
(Jantas et al. 2018a) which was significantly attenuated only
by Nec-1 + Curc combination (Table 3). Activation of this
enzyme participates in another form of cell damage, namely
pyroptosis (Espinosa-Oliva et al. 2019; Wang et al. 2019).
Since previous data showed the activation of this pro-
inflammatory protease in neuronal cell type, including SH-
SY5Y cells and neuroprotective potency of its inhibitors
(Chen et al. 2019; Knaryan et al. 2014; Nath et al. 1996;
Zhao et al. 2019a, b), it is highly probable that this mecha-
nisms could be responsible for synergistic protective action of
Nec-1 and curcumin against H2O2-evoked cell damage, ob-
served in the present study.
Collectively, our data showed neuroprotective effects of the
necroptosis inhibitor, Nec-1 against oxidative stress–induced
cell damage, and pointed to involvement of cathepsin D inhi-
bition in the mechanism of its action. Moreover, a cell type–
specific interplay between necroptosis and apoptosis has been
demonstrated (Fig. 10).
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